PR

Padma Rajindar Mital

Director Director DIN 02222219
DIN 02222219 First appointment Mar 1988 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 1988
Shareholding value •••• Premium profile

About Padma Rajindar Mital

Data last updated:

Padma Rajindar Mital was a Director at Sumit Biosciences Private Limited (1988–2015) and Director at Inditalia Refcon Ltd (2008–2015). The companies operate in Healthcare and Transport and Logistics.

DIN 02222219
Primary Designation Director
Industry Healthcare
First Appointment 08 Mar 1988

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sumit Biosciences Private Limited U51900MH1988PTC046424
Director08 Mar 19881988₹44.5 Lakh (FY 2024)Active
Inditalia Refcon Ltd L28129MH1986PLC039591
Director18 Jun 20081986Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sumit Biosciences Private Limited
Inditalia Refcon Ltd
Premium access

Shareholding and investment profile for Padma Rajindar Mital

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padma Rajindar Mital

Padma Rajindar Mital was first appointed on 08 Mar 1988 as Director at Sumit Biosciences Private Limited. The most recent appointment on record is 18 Jun 2008 at Inditalia Refcon Ltd.

Padma Rajindar Mital held 2 earlier board appointments: Sumit Biosciences Private Limited (Director, 08 Mar 1988 to 15 Sep 2015); Inditalia Refcon Ltd (Director, 18 Jun 2008 to 12 Mar 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available